Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4264183 | 0.79 | ALDH1A1 (0.43) | KDM4EALDH1A1USP2ALOX15TDP1 | |
| SCHEMBL7533791 | 0.79 | KDM4E (0.40) | KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL5873088 | 0.79 | EPHX2 (0.32) | KDM4EALDH1A1EPHX2MEN1KMT2A | |
| SCHEMBL5873001 | 0.78 | ALDH1A1 (0.41) | KDM4EALDH1A1ALOX15TDP1EPHX2 | |
| SCHEMBL5872938 | 0.75 | KDM4E (0.33) | KDM4EALDH1A1ALOX15TDP1EPHX2 | |
| SCHEMBL32688759 | 0.73 | ALDH1A1 (0.40) | KDM4EALDH1A1ALOX15TDP1EPHX2 | |
| SCHEMBL4104590 | 0.73 | ALDH1A1 (0.40) | KDM4EALDH1A1ALOX15TDP1EPHX2 | |
| SCHEMBL19813191 | 0.72 | KDM4E (0.36) | KDM4EALDH1A1USP2ALOX15TDP1 | |
| SCHEMBL19096568 | 0.72 | ALDH1A1 (0.52) | KDM4EALDH1A1USP2ALOX15TDP1 | |
| SCHEMBL22263800 | 0.71 | KDM4E (0.38) | KDM4EALDH1A1ALOX15TDP1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7029822-B2 | Tertiary alcohol compounds having alicyclic structure | SHIN ETSU CHEMICAL CO., LTD. (JP) | 2006-04-18 | — | — | US | disclosed |
| US-20040254394-A1 | Novel tertiary alcohol compounds having alicyclic structure | HASEGAWA KOJI (JP) | 2004-12-16 | — | — | US | disclosed |
| US-6774258-B2 | USEFUL AS MONOMER TO FORM POLYMER WHICH SERVES AS A BASE RESIN IN CHEMICALLY AMPLIFIED RESIST | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2004-08-10 | — | — | US | disclosed |
| US-20020072579-A1 | Novel tertiary alcohol compounds having alicyclic structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254394-A1 | Novel tertiary alcohol compounds having alicyclic structure | ADH1A, ADH1C, ICAM1 | KDM4E 822/4885ALDH1A1 30/4885USP2 4286/4885 |
| US-20020072579-A1 | Novel tertiary alcohol compounds having alicyclic structure | ADH1A, ADH1C, ICAM1 | KDM4E 822/4885ALDH1A1 30/4885USP2 4286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.